TECHINNOVATION TECH OFFERS

Gum disease, a widespread and severe condition, often remains undetected until it progresses to advanced stages, leading to significant oral health issues and costly treatments. This AI-driven gum disease detection and management system is designed specifically for home use and caregiving environments, such as care homes. It enables non-specialists to monitor oral health effectively, providing an early and accurate gum disease screening. This technology empowers caregivers, family members, and individuals to take proactive steps in maintaining oral health, especially for care home residents and people with low mobility who may have limited access to regular dental care. Using advanced machine learning algorithms, the system analyses oral images provided by the users to detect early signs of gum disease with high accuracy. Early detection allows timely intervention, reducing the risk of severe gum issues and enhancing overall health. The AI system is user-friendly and requires minimal training to operate, making it ideal for non-professional settings. It addresses a significant market need by providing accessible, reliable, and cost-effective oral health monitoring tools, ensuring that quality oral care is available to those who need it most. This technology improves individual health outcomes and reduces the burden on professional dental services by enabling early disease management.

Controlling both outdoor and indoor air pollution is crucial for protecting human health and the environment. Outdoor air pollution from industrial emissions and vehicle exhaust contributes to respiratory and cardiovascular diseases, global warming, and environmental degradation. Indoor air pollution can also cause chronic respiratory conditions and other health issues. According to the World Health Organization (WHO), outdoor air pollution causes approximately 4.2 million premature deaths annually, while indoor air pollution accounts for around 3.8 million premature deaths each year. Traditionally, wet scrubbers are used to reduce air pollution, ensuring regulatory compliance and protecting human health. However, they have drawbacks such as scaling, fouling, inefficient pollutant removal, and generating solid waste. These issues lead to frequent maintenance, high operational costs, and environmental pollution. This technology addresses these pain points by utilizing an array of water jets without the need for packing materials. This innovative solution offers more efficient pollutant removal, reduced maintenance, a compact design, and lower energy consumption, effectively solving the problems associated with traditional wet scrubbers. The technology owner is seeking collaborations with companies in the chemical/ pharmaceutical/ steel manufacturing sector for test-bedding and research and development (R&D) projects that require an eco-friendly scrubber.

Dementia, particularly Alzheimer's disease, is a significant socioeconomic burden in aging societies. Traditional blood tests are unable to  detect Alzheimer's biomarkers despite that the biomarkers appear 10-20 years before the appearance of cognitive decline symptoms. A groundbreaking ultrasensitive blood biomarker detection technology has been developed to overcome this limitation. This patented technology detects disease biomarkers at femtogram (fg/mL) levels, achieving sensitivity over 10,000 times higher than conventional methods. In addition to advanced biomarker detection, a comprehensive lifelog data collection technology has been integrated. Using smart rings and other wearable devices, extensive lifelog data is gathered, including sleep patterns, activities, and urine test results. This multimodal data collection supports the creation of the world’s largest Asian Senior Cohort, targeting over 30,000 individuals for the next 5 years. A key component of this innovative approach is the AI-based data analysis for the diagnosis and prognosis of dementia and cognitive dysfunction. AI algorithms analyze the comprehensive datasets, providing precise diagnostic insights and predicting disease progression. This AI-driven analysis, combined with ultrasensitive biomarker detection and detailed lifelog data, forms a robust data platform for early diagnosis, continuous monitoring, and personalized healthcare solutions. By focusing on these cutting-edge technologies, this platform offers a holistic and precise approach to managing cognitive health in super-aging societies. This innovative solution supports precision medicine and provides a comprehensive method for the early detection and ongoing management of dementia and other age-related diseases.

Singapore is an aged society and is set to be “super-aged” in 2026. This means that 21% of the population are 65 years and above. In a recent study conducted in Singapore, 72% had some form of cognitive impairment. The number of young onset dementia is also on the rise in Singapore. This underscores the critical need for early detection and intervention. However, existing screening tools for dementia have limitations. Their ability to identify Mild Cognitive Impairment (MCI), an early stage of dementia, is limited. Additionally, these tools require specialized instructors for test administration and scoring, which can be inconvenient for seniors who must visit a facility for screening. This innovative app merges mobile technology with artificial intelligence to address these challenges. It outperforms the MMSE (mini-mental state examination), the most widely used dementia screening test, in identifying both Alzheimer’s disease and MCI. Furthermore, the AI-based automatic scoring system provides test results within one minute, eliminating the need for specially trained instructors. This feature makes the app accessible anywhere, including at home. By enhancing the accuracy, accessibility, and usability of dementia screening, the app aims to facilitate equitable access to essential healthcare resources and contribute to the well-being of individuals and communities.    

The company offers a suite of innovative automated liquid handling systems, hardware and software for process automation designed to enhance precision, efficiency, and scalability in biological research. The industry currently faces significant challenges with semi or full automation of laboratory equipment, including high costs, limited flexibility, and manual errors. These bottlenecks hinder the efficiency and reliability of complex laboratory processes. The company's technology addresses these issues with a range of flagship products that provide cutting-edge automation for tasks such as genomic and proteomic analysis, drug discovery, and clinical diagnostics. The systems feature modular assembly, allowing for easy customization and scalability to meet the evolving needs of life science laboratories. This flexibility ensures that the solutions can adapt to various experimental setups and requirements. One of the unique value proposition of the company's technology is its ability to significantly reduce costs up to 90% compared to traditional automation systems. This cost-effectiveness is achieved through innovative mechanical design, advanced software integration, and efficient hardware utilization. Additionally, the systems boast the largest consumables library in the industry, providing researchers with a wide range of options to support their specific needs. The company is actively seeking software and OEM partnerships to further enhance its product offerings and expand its market reach. By collaborating with key partners, it aims to continue driving innovation and providing top-tier solutions to the life sciences industry.

In the development of communication networks, various challenges emerge in achieving wireless signal coverage in certain areas, while the cost of deploying traditional wired Ethernet remains prohibitive in specific locations. Industries accustomed to slower wired communications now seek high-speed alternatives to facilitate IoT integration and enhance operational efficiency, yet they are hesitant to undertake extensive rewiring efforts. Building networks across diverse settings, including buildings, condominiums, and factories, often encounters significant cost hurdles. This is primarily due to the need for multiple Wi-Fi repeaters to cover areas with poor signal reach, as well as the requirement for numerous network switches and construction work involving cable installation under floors and above ceilings. A solution lies in technology that facilitates data communication over existing wires within facilities, such as flat cables, twisted pair wires, coaxial cables, and power lines. The effective communication speed varies from several Mbps to several tens of Mbps, depending on the type of cable and the wiring environment. Moreover, this technology seamlessly integrates with Wi-Fi, Ethernet, and other existing infrastructures, providing a cost-effective approach to network construction. By leveraging these technologies, it becomes feasible to establish society's network infrastructure at a reduced cost, particularly in challenging environments such as concrete structures, underground areas, tunnels, and spaces with metal walls.

Bioprocessing technologies used in scaling manufacturing production typically uses scale-up and scale-out approaches through microcarrier-based stirred tank bioreactors, wave bags or cell stackers and multi-layered flasks. However, during the research and development process of cell and gene therapies, there is a significant technical gap between basic research methods and these manufacturing process development, which causes problems such as increase in time and cost of the development process. Cell and Gene Therapy manufacturing is an emerging area in the biopharmaceutical industry that must overcome high barriers of resource, capacity, and cost constraints. Therefore, it is extremely important to consistently consider and design a culture process from R&D to commercialization as a closed system with a certain size of scale-up and automation.  This technology introduces a robust and economically viable culture process in a closed culture system which comprises of an automated cell culture medium change device that can be installed in commercial CO2 incubators, where the device is coupled with a patented microwell bag and V-shaped adhesion cell culture bag, capable of both spheroid culture (3D) and adhesion culture (2D). This novel technology has established a culture method that meets the requirements of clinical use by improving sterility, reproducibility, and operability, and produces a large number of uniform-sized clusters. The technology owner is seeking partnerships and collaborations with institutions, hospitals, biotechnology and biopharmaceutical firms. 

Paper packaging is a versatile material used for a wide range of products. Its widespread adoption is due to its renewable and relatively low-cost resource along with environmental benefits such as recyclability and biodegradability. While paper packaging offers several advantages, some drawbacks of the material include porosity and the lack of barrier properties against moisture, oil, and grease. To overcome these limitations, conventional coatings such as polyethylene (PE) or polyfluoroalkyl substances (PFAS) have been employed to impart the required barrier protection. However, during the paper recycling process, it is difficult to repulp the coated paper due to several factors and results in reduced recyclability of such packaging materials. The technology on offer is a water-based coating formulation that can be applied onto paper packaging surfaces to act as a barrier against grease, liquid water, and water vapour. The coating imparts barrier protection functionalities, improving the paper’s resistance to grease, liquid water, and water vapor significantly. Use of bio-sourced constituents in the coating also improves product sustainability. As the coating’s constituents are repulpable, recyclability of the paper packaging can be achieved. With increasing awareness of reducing packaging waste, the deployment of this technology will offer companies a recyclable paper packaging with notable barrier properties. The technology owner is seeking for R&D co-development, test bedding and IP out licensing opportunities of this technology with interested companies.

The Reconfigurable Workspace Soft Gripper (RWSG) is a bio-inspired, pneumatically actuated, shape morphing soft robotic gripper that is capable of rapid reconfigurability. It features passive retractable nails, bi-directional foldable petals, and a flexible palm to adapt to various grasping and manipulation tasks and requirements. The ability to rapidly reconfigure allows the RWSG to grasp a wide range of large, thin, hard, delicate, and deformable objects. These capabilities make the RWSG a uniquely advantageous tool for high mix low volume manipulation and packing scenarios such as food assembly, packaging of groceries, and packing of consumer electronics.